Tenderwize
Back to tender search

Pharmaceutical product with active ingredient Aripiprazole (ATC: N05AX12 - for parenteral administration)

AOK Sachsen-Anhalt - Die Gesundheitskasse·Magdeburg, Germany·Deadline Mar 30, 2027 · 171 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Aripiprazol (ATC: N05AX12 - für die parenterale Applikation)

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

15 / 100

Risk factors

The buyer may terminate contracts if exclusive contracts for the same active ingredient are later tendered during the c...

No estimated value or minimum volume is provided, making it impossible to assess potential revenue.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Sachsen-Anhalt - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for pharmaceutical products with Aripiprazole (parenteral application) under an open-house model.
  • Any qualified pharmaceutical company can conclude a contract at any time under uniform conditions.
Show full summary

This is a notice for non-exclusive discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for pharmaceutical products containing Aripiprazole (ATC: N05AX12, parenteral application) issued by AOK Sachsen-Anhalt. The procurement follows an 'open-house model' allowing any qualified pharmaceutical company to join at any time during the contract period (01.06.2025 to 31.05.2027). The tender is explicitly not a public procurement under EU law but published for transparency. No estimated value or award criteria are specified; all eligible companies get a contract without competition. The deadline for submission is 31.03.2027, with contracts starting as early as 01.06.2025.

Risks

The buyer may terminate contracts if exclusive contracts for the same active ingredient are later tendered during the c...

No estimated value or minimum volume is provided, making it impossible to assess potential revenue.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company or a group of pharmaceutical companies.

Administrative

  • Must complete and sign the participation documents.
  • Electronic submission allowed only via qualified electronic signature (eIDAS Regulation) to [email protected].

Requirements may be incomplete.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Pharmaceutical product with active ingredient Aripiprazole (ATC: N05AX12 - for parenteral administration)

Non-exclusive discount agreements for finished medicinal products with Aripiprazole (parenteral). The contract is open to all qualifying pharmaceutical companies at any time. No exclusivity; contracts end on 31.05.2027 regardless of start date. The buyer may terminate if exclusive contracts are later tendered.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Deadline

Deadline Mar 30, 2027

Procurement Details

Publication date
09 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
232943-2025

Documents (1)

Similar tenders